Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Priority Review Voucher Fee Decreases For FY 2021 May Reflect US FDA Personnel Changes
Oct 05 2020
•
By
Derrick Gingery
The FY 2021 priority review voucher user fee decreased more than 37% from the previous year. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from Pathways & Standards